Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway.
Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, Yang R, Uddin J, Guggino WB, Atabani SF, Belkaid Y, Xu Y, Whitsett JA, Accurso FJ, Wills-Karp M, Petasis NA.
Karp CL, et al. Among authors: xu y.
Nat Immunol. 2004 Apr;5(4):388-92. doi: 10.1038/ni1056. Epub 2004 Mar 21.
Nat Immunol. 2004.
PMID: 15034576